Ending cancer as we know it—for everyone—begins with the numbers

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

January is always an exciting time for the American Cancer Society. Every year since 1951, ACS has published Cancer Facts & Figures(CFF), a summary of the most up-to-date population-based cancer data in the United States.  This report, and its accompanying scientific article, Cancer Statistics, published in CA: A Cancer Journal for Clinicians, are the most...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
William L. Dahut, MD
Chief scientific officer, American Cancer Society
Table of Contents

YOU MAY BE INTERESTED IN

For decades, we have faced a central challenge in colorectal cancer screening. One in three eligible Americans—over 50 million people—remain unscreened despite established methods like colonoscopy or stool-based tests existing for decades. This gap persists even though early detection saves lives, and even as colorectal cancer is now the number one cancer killer for Americans under 50.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
If you believe in the miraculous healing power of ivermectin, hydroxychloroquine, and the harm from vaccination for HPV and COVID-19, you’ve got a powerful friend in Sen. Ron Johnson (R-WI), chair of the Permanent Subcommittee on Investigations of the Senate Committee on Homeland Security and Governmental Affairs.
William L. Dahut, MD
Chief scientific officer, American Cancer Society

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login